JP2009525981A5 - - Google Patents

Download PDF

Info

Publication number
JP2009525981A5
JP2009525981A5 JP2008553486A JP2008553486A JP2009525981A5 JP 2009525981 A5 JP2009525981 A5 JP 2009525981A5 JP 2008553486 A JP2008553486 A JP 2008553486A JP 2008553486 A JP2008553486 A JP 2008553486A JP 2009525981 A5 JP2009525981 A5 JP 2009525981A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
insufficient
disease
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008553486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009525981A (ja
JP5113766B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061404 external-priority patent/WO2007092721A2/en
Publication of JP2009525981A publication Critical patent/JP2009525981A/ja
Publication of JP2009525981A5 publication Critical patent/JP2009525981A5/ja
Application granted granted Critical
Publication of JP5113766B2 publication Critical patent/JP5113766B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008553486A 2006-02-02 2007-01-31 ビタミンd類似体:rak、その方法および使用 Expired - Fee Related JP5113766B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74321906P 2006-02-02 2006-02-02
US60/743,219 2006-02-02
PCT/US2007/061404 WO2007092721A2 (en) 2006-02-02 2007-01-31 Vitamin d analog: rak, methods and uses thereof

Publications (3)

Publication Number Publication Date
JP2009525981A JP2009525981A (ja) 2009-07-16
JP2009525981A5 true JP2009525981A5 (https=) 2009-11-26
JP5113766B2 JP5113766B2 (ja) 2013-01-09

Family

ID=38330725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008553486A Expired - Fee Related JP5113766B2 (ja) 2006-02-02 2007-01-31 ビタミンd類似体:rak、その方法および使用

Country Status (10)

Country Link
US (1) US7803789B2 (https=)
EP (1) EP1984329B1 (https=)
JP (1) JP5113766B2 (https=)
AT (1) ATE451352T1 (https=)
AU (1) AU2007212185B2 (https=)
CA (1) CA2637302C (https=)
DE (1) DE602007003691D1 (https=)
ES (1) ES2339402T3 (https=)
NZ (1) NZ569690A (https=)
WO (1) WO2007092721A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009533483A (ja) * 2006-04-06 2009-09-17 ウイスコンシン アラムニ リサーチ ファンデーション 2−メチレン−1α,25−ジヒドロキシ−18,19,21−トリノルビタミンD3およびその使用
US7648973B2 (en) * 2006-04-06 2010-01-19 Wisconsin Alumni Research Foundation 2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof
CA2646909A1 (en) * 2006-04-06 2008-03-27 Hector F. Deluca 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
MX2008012671A (es) 2006-04-06 2008-10-15 Wisconsin Alumni Res Found Analogos 1 a,25-dihidroxi- 19, 26,27-trinor vitamina d 2-sustituidos y sus usos.
WO2008026078A2 (en) * 2006-04-06 2008-03-06 Wisconsin Alumni Research Foundation 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring
AU2007298651A1 (en) * 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
DE602007012216D1 (de) * 2006-04-10 2011-03-10 Wisconsin Alumni Res Found 1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor-vitamin-d-verbindungen mit einer 1,1-dimethylpropyl-seitenkette
CA2710970A1 (en) * 2007-12-28 2009-07-09 Wisconsin Alumni Research Foundation 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
EP2240440A2 (en) * 2007-12-28 2010-10-20 Wisconsin Alumni Research Foundation 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
US7648974B1 (en) * 2008-07-10 2010-01-19 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US7879829B2 (en) * 2008-07-10 2011-02-01 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2-dihydrofuran ring
US8193170B2 (en) 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US8399439B2 (en) 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
US8217023B2 (en) 2009-10-02 2012-07-10 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
EP2525799B1 (en) 2009-10-02 2014-09-03 Wisconsin Alumni Research Foundation (20s,22e)-2-methylene-19-nor-22-ene-1alpha,25-dihydroxyvitamin d3 analogs
MX339926B (es) * 2010-09-30 2016-06-16 Wisconsin Alumni Res Found * (20r, 25s)-metilen-19,26-dinor-1a,25-dihidroxivitamina d3 en forma cristalina.
JP6035331B2 (ja) * 2011-06-14 2016-11-30 ウイスコンシン アラムニ リサーチ ファンデーション 3−デスオキシ−2−メチレン−19−ノル−ビタミンd類似体およびそれらの使用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666634A (en) 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
US5086191A (en) 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
DE69400495T2 (de) 1993-04-05 1997-04-30 Wisconsin Alumni Res Found 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5945410A (en) 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6306844B1 (en) * 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US6806262B2 (en) * 2000-05-31 2004-10-19 Wisconsin Alumni Research Foundation 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
WO2002020021A1 (en) 2000-09-08 2002-03-14 Wisconsin Alumni Research Foundation 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
WO2002094247A2 (en) 2001-05-22 2002-11-28 Bioxell S.P.A. Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6566352B1 (en) 2002-02-18 2003-05-20 Wisconsin Alumni Research Foudation 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
US20030195175A1 (en) 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
GB0305332D0 (en) 2003-03-10 2003-04-09 Leuven K U Res & Dev Biological evaluation of novel vitamin D analogues
US6894037B2 (en) * 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
US20050009792A1 (en) 2003-07-08 2005-01-13 Deluca Hector F. (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
CA2539361A1 (en) 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
US7053075B2 (en) 2003-11-25 2006-05-30 Deluca Hector F Methods for reducing body fat using vitamin D compounds
CA2544502A1 (en) 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
JP2008520689A (ja) * 2004-11-22 2008-06-19 ウィスコンシン・アルムニ・リサーチ・ファウンデーション 19,26,27−トリノル−(20S)−1α−ヒドロキシビタミンD3の2α−メチルおよび2β−メチル類似体およびそれらの使用
AU2006230296B2 (en) * 2005-03-29 2011-07-07 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone
CA2605727A1 (en) 2005-05-03 2006-11-09 Wisconsin Alumni Research Foundation 19,26,27-trinor-1.alpha.,25-dihydroxyvitamin d3 compounds
US7528122B2 (en) * 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
CA2646909A1 (en) * 2006-04-06 2008-03-27 Hector F. Deluca 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof

Similar Documents

Publication Publication Date Title
JP2009525981A5 (https=)
JP2010505739A5 (https=)
JP2009532458A5 (https=)
WO2006009092A1 (ja) 効果的な医薬の使用法及び副作用発現の防御に関する方法
CN1812812B (zh) 降血清胆固醇药或者动脉粥样硬化的预防或治疗药
EP2521707A1 (en) Bisphenol derivatives and their use as androgen receptor activity modulators
EP3148970B1 (en) Androgen receptor modulators and methods for their use
JP2007502832A5 (https=)
JP2009185034A5 (https=)
JP2007526331A5 (https=)
JP2008520703A5 (https=)
JP2013522369A5 (https=)
EP4516774A2 (en) Modulators of liver receptor homologue 1 (lrh-1) and uses
JP2019534865A5 (https=)
JP2008530110A5 (https=)
JP2006510658A5 (https=)
JP2008520709A5 (https=)
JP2006523239A5 (https=)
JP2008520690A5 (https=)
JP2008520705A5 (https=)
JP2008520708A5 (https=)
US12357612B2 (en) Prophylactic or therapeutic agent for cancer
NZ570711A (en) 2-Substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
JP2008528617A5 (https=)
EP2709998A1 (en) Substituted indole derivatives for the treatment of immunological disorders